India’s Mapmygenome Eyes $20m Series A
This article was originally published in Clinica
Mapmygenome, an Indian personal genomics and predictive testing start-up, is looking to raise around $20m in Series A funding to build and expand its operations.
You may also be interested in...
Scrip traces some of the prominent changes in the corner office at front-line, family-owned Indian firms Cipla and Dr Reddy’s in the decade gone by.
Glenmark has struck a deal with private equity firm True North for its gynecology business in India and Nepal.
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.